AzTrials
AzTrials

Sleep QualitySleepScanNCT05963672

Assessment of Sleep Quality of Hospitalized Patients Treated With EEG-guided Protection Procedures: Application in Intensive Care Unit

A study testing EEG-guided sleep protection in people with Sleep Quality and Critically Ill Patient, run by Poitiers University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sleep of critically ill patients is highly disturbed with a high sleep fragmentation; patients spend most of their sleep in very short sleep episodes, lasting less than 10 minutes. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
EEG-guided sleep protection
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteFrance
Study dates
8 Aug 2023to 20 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults admitted in medical ICU of University Hospital of Poitiers
  • Un-sedated patients displaying a RASS scale between -2 and +1
  • Intubated or spontaneously breathing patients
  • Patient or family have signed the inform consent

Who cannot join

  • Patients with a central nervous system disease altering sleep scoring
  • Patients who received drugs (<24h) modifying significantly EEG and sleep scoring
  • Patients with cutaneous erosion of the scalp

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Poitiers

    Poitiers, 86000

Other trials in France

About this study

Official title: Assessment of Sleep Quality of Hospitalized Patients Treated With EEG-guided Protection Procedures: Application in Intensive Care Unit. (SleepScan)

Sleep of critically ill patients is highly disturbed with a high sleep fragmentation; patients spend most of their sleep in very short sleep episodes, lasting less than 10 minutes. Causes of theses sleep alterations are complex including environmental noise (alarms, beepers, conversations…), continuous light, nurse care and repetitive measures of vital parameters.

Numerous studies have reported a relationship between severe sleep alterations and a prolonged weaning period and mortality. Improving sleep quality in critically ill patients is a major challenge to promote ICU patient's recovery.

Read more

A very promising treatment is the application of a nocturnal " quiet-time " during which non urgent care, comfort care, systematic measures of vital parameters are delayed and clustered in order to limit room entries. However, " quiet time " procedures have failed to improve sleep quality to date.

A miniaturized medical device recording one EEG channel and embedding an automated sleep scoring algorithm running in real-time was devised. This device (positioned on forehead, and continuously recording noise and light levels) indicates if the patient is awake or asleep using a tablet positioned at doorstep of the room, so that nurses know if patient is sleeping, without entering the room.

Hypothesis proposes that applying sleep protection procedures (clustering cares, limiting room entries, reducing lights and noise, delaying non urgent care…) when patients are sleeping (= EEG-guided strategies) will increase patients sleep quality.

This study will assess the effect of such device on sleep quality in ICU patients. This is a "before / after" design. The first group ("control group"), will be recorded but the sleep scoring will not be displayed by the tablet and patient will be expose to standard care. Then, procedure will be established collegially with nurses, nurses assistants and doctors. Then, the second group ("treated group") will be recorded with the device displaying the status of the patient (asleep/awake) and all caregivers will be asked to follow the established rules ("EEG-guided sleep protection rules")

Being tested
EEG-guided sleep protection, Control condition
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EEG-guided sleep protectionDevice

    The tablet will display a specific picture "prioritize sleep" or "prioritize care" depending on the patient status determined by the algorithm. When the picture "favor/prioritize sleep" is displayed, all caregivers and visiting family are asked to follow the sleep protection rules: refrain to enter the room for not urgent reasons, switch off television, reduced light in the room/corridor, reduce noise in front of the door, close curtain (if any), and delay non urgent care…etc; if caregivers have to enter the room, headlight and/or additional light will be favored. All these rules will be established collegially by nurses and doctors. Obviously, urgent care and reactions to alarms are maintained.

    When the picture "favor/prioritize care" is displayed, all caregivers and visiting family are invited to perform non urgent care, cleaning, restocking perfusion needles, comfort care, visiting.

  • Control conditionOther

    the recording device will be placed on the patient to record sleep but the tablet will be masked and placed face down on the bench in the room, invisible from the door.

Study groups in NCT05963672
Study groupRoleWhat they receive
Usual CareSham comparatorNot described
Receives: Other: Control condition
EEG-guided sleep protectionExperimentalNot described
Receives: Device: EEG-guided sleep protection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sleep quality

    Proportion of continuous sleep

    Measured: Day 1 to Day 4

Secondary outcomes (14)
  1. Sleep fragmentation

    Number of awakenings and micro-awakenings per hour of sleep

    Measured: Day 1 to Day 4

  2. Environmental noise and environmental light

    Number of peak noise end time spent above 20 lux

    Measured: Day 1 to Day 4

  3. Sleep interruptions by caregivers

    Number of room entries while patient is asleep

    Measured: Day 1 to Day 4

  4. Sleep quality

    Proportion of continuous sleep

    Measured: Day 2 to Day 4

  5. Workload assessed by nurses

    Score at specific scale assessing workload. From 1- no workload to 10- significant additional workload.

    Measured: Day 1 to Day 4

  6. Patient Agitation

    Number of patients with diminishing (-1 point) Richmond Agitation-Sedation Scale (RASS) score. 10 Agitation-Sedation scale items From +4 (combative) to -5 (non-recoverable)

    Measured: Day 1 to day 4

  7. Performance of the algorithm

    Number of sleep episodes lasting more than 10 min correctly identified by algorithm (versus vision scoring)

    Measured: Day 1 to Day 4

  8. Patient reported sleep quality

    Score et richards-Campbell sleep questionnaire. It consist of 6 questions, each question scored from 0 to 100. Higher score mean the better sleep

    Measured: Day 1 to day 4

  9. Anxiety level

    Score at Spielberger Y-A scale.It consist of 12 questions, each rated on a scale with 4 response options. Lower score means a minimal anxiety level.

    Measured: Day 1 to day 4

  10. Respiratory status

    Weaning duration (number of days), ventilator free days and respiratory status at discharge

    Measured: At Unit care discharge, an average of 14 days

  11. Presence of delirium

    Number of days with positive Confusion Assessment Method(CAM)-ICU scale. It is made up of 4 criteria. The test is POSITIVE (confusion present) if 1 and 2 + 3 or 4 are met.

    Measured: Day 1 to Day 4

  12. Unit Care length of stay

    Number of days in ICU

    Measured: At Unit care discharge, an average of 14 days

  13. Safety of the procedure

    Numbers of Serious adverse events and Material defect events

    Measured: One day after Unit Care discharge, an average of 15 days

  14. Sleep continuity

    Part of sleep time past in more than 10 minutes episodes

    Measured: Day 1 to Day 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start8 Aug 2023
  3. Primary completion14 Jul 2024
  4. Study completion20 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05963672
Sponsor's protocol ID
SleepScan
Acronym
SleepScan
Status last verified
Sep 2024
First submitted
19 Jun 2023
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing EEG-guided sleep protection in people with Sleep Quality and Critically Ill Patient, run by Poitiers University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sleep quality (time frame: Day 1 to Day 4). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in